These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11900391

  • 1. Laboratory testing in diabetes mellitus.
    Leroux M.
    Adv Exp Med Biol; 2001; 498():359-66. PubMed ID: 11900391
    [No Abstract] [Full Text] [Related]

  • 2. Serum fructosamine as a screening test for type 2 diabetes.
    Klonoff DC.
    Diabetes Technol Ther; 2000; 2(4):537-9. PubMed ID: 11469616
    [No Abstract] [Full Text] [Related]

  • 3. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
    Edelman SV, Callahan P, Deeb LC.
    Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264
    [Abstract] [Full Text] [Related]

  • 4. GHb (HbA(1c)) is more sensitive than fasting blood glucose as a screening test for diabetes.
    Papoz L, Favier F, Clabé A, Sanchez A, Le Moullec N.
    Diabetes Care; 2000 Aug; 23(8):1206-7; author reply 1208. PubMed ID: 10937531
    [No Abstract] [Full Text] [Related]

  • 5. Use of GHb (HbA(1c)) to screen for undiagnosed diabetes in the U.S. population.
    Herman WH, Engelgau MM, Zhang Y, Brown MB.
    Diabetes Care; 2000 Aug; 23(8):1207-8. PubMed ID: 10937532
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test.
    Herdzik E, Safranow K, Ciechanowski K.
    Acta Diabetol; 2002 Apr; 39(1):15-22. PubMed ID: 12043934
    [Abstract] [Full Text] [Related]

  • 7. The diagnosis of diabetes is changing: how implementation of hemoglobin A1c will impact clinical laboratories.
    Sacks DB.
    Clin Chem; 2009 Sep; 55(9):1612-4. PubMed ID: 19589842
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [Abstract] [Full Text] [Related]

  • 14. Tests of glycemia in diabetes.
    Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM.
    Diabetes Care; 1995 Jun; 18(6):896-909. PubMed ID: 7555528
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tests of glycemia in diabetes.
    American Diabetes Association.
    Diabetes Care; 2000 Jan; 23 Suppl 1():S80-2. PubMed ID: 12017687
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fructosamine and glycated hemoglobin in the assessment of glycaemic control in dogs.
    Loste A, Marca MC.
    Vet Res; 2001 Jan; 32(1):55-62. PubMed ID: 11254177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Commentary.
    Fisher SJ.
    Clin Chem; 2011 Feb; 57(2):157. PubMed ID: 21278360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.